U.S., Nov. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07228559) titled 'A Study of Avoralstat In Participants With Diabetic Macular Edema' on Sept. 26.
Brief Summary: The goal of this study is to assess the safety and therapeutic potential of a single dose of avoralstat in adult participants with DME.
Study Start Date: Oct. 02
Study Type: INTERVENTIONAL
Condition:
Diabetic Macular Edema (DME)
Intervention:
DRUG: avoralstat
BCX4161 for suprachoroidal injection
Recruitment Status: RECRUITING
Sponsor: BioCryst Pharmaceuticals
Published by HT Digital Content Services with permission from Health Daily Digest....